Burning Rock Biotech Limited (BNR)

Burning Rock Biotech Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 17, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	459	217	69	98	237	996
Market Cap Growth	587.88%	213.30%	-29.38%	-58.57%	-76.25%	-58.45%
Enterprise Value	386	156	13	13	103	755
Last Close Price	16.99	20.15	6.75	9.30	22.50	95.30
PS Ratio	5.80	2.81	0.98	1.29	2.90	12.46
PB Ratio	2.33	2.84	0.87	0.91	1.41	3.43
P/TBV Ratio	5.85	2.84	0.87	0.91	1.41	3.44
EV/Sales Ratio	5.00	2.03	0.18	0.18	1.27	9.44
Debt / Equity Ratio	0.08	0.08	0.09	0.02	0.04	0.05
Debt / EBITDA Ratio	1.52	1.52	-	-	-	-
Net Debt / Equity Ratio	-0.81	-0.81	-0.81	-0.80	-0.74	-0.76
Net Debt / EBITDA Ratio	125.87	125.87	1.75	1.15	1.00	1.87
Net Debt / FCF Ratio	15.30	15.30	4.85	2.34	1.63	2.05
Asset Turnover	0.63	0.63	0.54	0.41	0.29	0.21
Inventory Turnover	2.29	2.29	2.33	1.75	1.45	1.50
Quick Ratio	2.67	2.67	2.60	2.96	2.58	4.38
Current Ratio	2.99	2.99	2.92	3.36	3.06	4.89
Return on Equity (ROE)	-9.92%	-9.92%	-51.38%	-67.85%	-64.67%	-37.35%
Return on Assets (ROA)	-4.02%	-4.02%	-20.93%	-31.84%	-31.70%	-20.16%
Return on Capital Employed (ROCE)	-9.60%	-9.60%	-52.10%	-86.20%	-83.40%	-41.80%
Earnings Yield	-1.77%	-3.65%	-68.58%	-94.01%	-59.50%	-12.59%
FCF Yield	-0.92%	-1.87%	-19.33%	-37.95%	-32.29%	-10.88%
Buyback Yield / Dilution	-4.78%	-4.78%	-0.53%	1.46%	0.29%	-51.83%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q